# A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers

> **NCT04774874** · PHASE2 · COMPLETED · sponsor: **Follicum AB** · enrollment: 209 (actual)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DRUG:** Topical formulation

## Key facts

- **NCT ID:** NCT04774874
- **Lead sponsor:** Follicum AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-24
- **Primary completion:** 2021-01-29
- **Final completion:** 2021-01-29
- **Target enrollment:** 209 (ACTUAL)
- **Last updated:** 2021-03-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04774874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04774874, "A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04774874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*